Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Retroperitoneal liposarcoma]

S Lauretti1, M Cappa, P Emiliozzi

  • 1Divisione di Urologia, Ospedale CTO, Roma.

Minerva Chirurgica
|May 13, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extraperitoneal robot assisted laparoscopic prostatectomy with Versius system: single centre experience.

Prostate cancer and prostatic diseases·2024
Same author

The economic burden of pediatric growth hormone deficiency in Italy: a cost of illness study.

Journal of endocrinological investigation·2024
Same author

Quality of life in children and adolescents with growth hormone deficiency and their caregivers: an Italian survey.

Journal of endocrinological investigation·2023
Same author

High 1-h glucose in youths with obesity as marker of prediabetes and cardiovascular risk.

Journal of endocrinological investigation·2023
Same author

Multicentric Italian case-control study on 25OH vitamin D levels in children and adolescents with Prader-Willi syndrome.

Journal of endocrinological investigation·2023
Same author

Appropriate management of growth hormone deficiency during the age of transition: an Italian Delphi consensus statement.

Journal of endocrinological investigation·2022
Same journal

Unexpected evolution of COVID-19 in a heart transplant patient with multimorbidity recently submitted to thoracic surgery.

Minerva chirurgica·2020
Same journal

Ongoing clinical trials on axillary management.

Minerva chirurgica·2020
Same journal

Axillary management after neoadjuvant treatment.

Minerva chirurgica·2020
Same journal

Axillary observation alone versus sentinel node biopsy: past, present and future perspectives.

Minerva chirurgica·2020
Same journal

Patient flow for the management of ostomy patients.

Minerva chirurgica·2020
Same journal

The management of "fragile" and suspected COVID-19 surgical patients during pandemic: an Italian single-center experience.

Minerva chirurgica·2020
See all related articles

This case report details a rare retroperitoneal liposarcoma, a large, aggressive soft-tissue tumor. Despite surgical resection and radiotherapy, the patient experienced recurrence and poor prognosis, highlighting challenges in treating these rare cancers.

Area of Science:

  • Oncology
  • Surgical Pathology

Background:

  • Retroperitoneal soft-tissue sarcomas are rare, locally invasive mesenchymal tumors peaking in the fifth decade.
  • Liposarcomas, often large, can grow asymptomatically in the retroperitoneum until invading local tissues.

Observation:

  • A 61-year-old man presented with an abdominal mass, weight loss, and persistent fever due to tumor necrosis, indicative of a retroperitoneal liposarcoma.
  • Computed tomography suggested the diagnosis, with a significant tumor weight (8.56 kg) and pleomorphic, undifferentiated (grade 3) histology.

Findings:

  • The patient underwent surgical resection with splenectomy and received postoperative radiotherapy.
  • Histological evaluation revealed a grade 3 pleomorphic liposarcoma with tumor giant cells and lipoblasts.
  • Conventional chemotherapy showed limited efficacy, and local recurrences are common, impacting prognosis.

Related Experiment Videos

Implications:

  • This case underscores the aggressive nature of high-grade retroperitoneal liposarcomas and the challenges in achieving long-term survival.
  • Complete surgical resection and radiotherapy are crucial, but recurrence necessitates further interventions, with a generally poor prognosis and limited 5-year survival rates (15-50%).